Senate Bill 0492
| || |
DIGEST OF INTRODUCED BILL
Medicaid generic drug reimbursement program. Requires the drug utilization review board (board) to develop, implement, and maintain a generically equivalent drug product Medicaid reimbursement program (program). Requires the manufacturer of a generically equivalent drug product to submit the cost that it would offer to a Medicaid provider for its drug in order to participate in the Medicaid program, and specifies that the cost may not exceed the maximum allowable rate determined by the office of Medicaid policy and planning. Requires the board to review the submissions and determine a Medicaid reimbursement rate for the therapeutic drug classification. Requires the office of Medicaid policy and planning to reimburse Medicaid providers at the rate determined by the board for the therapeutic drug classification. Establishes a time line for the implementation of the program for certain therapeutic drug classifications.
>Latest Printing > (PDF)
| ||In Committee - first House|